NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C909. A total of 4 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,268,750 | -31.7% | 73,500 | -42.7% | 0.00% | -25.0% |
| Q2 2023 | $12,098,690 | +1306.2% | 128,300 | +1409.4% | 0.00% | – |
| Q1 2023 | $860,370 | -89.5% | 8,500 | -87.6% | 0.00% | -100.0% |
| Q4 2022 | $8,169,696 | -26.5% | 68,400 | -34.7% | 0.00% | -20.0% |
| Q3 2022 | $11,120,000 | -80.6% | 104,700 | -82.2% | 0.01% | -79.2% |
| Q2 2022 | $57,192,000 | – | 586,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 25 | $240,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 31,300 | $3,000,000 | 0.01% |
| SIMPLEX TRADING, LLC | 235 | $2,252,000 | 0.00% |
| Interchange Capital Partners, LLC | 2 | $1,000 | 0.00% |
| JPMORGAN CHASE & CO | 41,800 | $4,007,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |